linker-mm1: linvoseltamab, a bispecific antibody, in r/r multiple myeloma
Published 11 months ago • 245 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
5:15
linker-mm1: linvoseltamab in patients with r/r multiple myeloma
-
3:12
updated results of the linker-mm1 trial: linvoseltamab in r/r multiple myeloma
-
1:33
updates from the linker-mm1 study: linvoseltamab in r/r multiple myeloma
-
2:57
linker-mm1: promising safety and efficacy of linvoseltamab in r/r multiple myeloma
-
10:57
linker-mm1 study: linvoseltamab (regn5458) in patients with rr multiple myeloma | asco 2023
-
3:16
end stage multiple myeloma
-
6:07
blood analysis in multiple myeloma
-
11:29
multiple myeloma basics - anaemia
-
4:00
updates from linker-mm1: safety and efficacy of linvoseltamab in patients with r/r multiple myeloma
-
2:28
the encouraging results of the linker-mm1 trial: safety and efficacy of linvoseltamab in r/r myeloma
-
1:25
safety and efficacy of linvoseltamab for patients with r/r multiple myeloma
-
4:45
a first-in-human trial of linvoseltamab (regn5458) in r/r myeloma: updated phase i data
-
1:56
investigating linvoseltamab monotherapy in smm: the linker-smm1 trial
-
1:47
insights into the efficacy of linvoseltamab in the treatment of r/r multiple myeloma
-
5:51
hans lee, md, on the linker-mm1 study of linvoseltamab in multiple myeloma
-
0:59
defining the origins of multiple myeloma
-
0:45
majestec-2 update: teclistamab plus lenalidomide in r/r multiple myeloma
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
2:33
the role of bispecific antibodies in the treatment of patients with multiple myeloma
-
0:46
2-year follow-up of majestec-1: teclistamab in r/r multiple myeloma
-
10:11
monumental-1: talquetamab in r/r multiple myeloma
-
1:23
association of sbcma with measures of disease burden & response to linvoseltamab in r/r myeloma